Rocket One Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Rocket One Inc.
- Former names
- Hoth Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Hoboken
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RKTO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001711786
- EIN
- 82-1553794
Board of directors
-
Christopher Michael Camarra · DirectorSince 2025
-
David Sarnoff · DirectorSince 2023
-
Graig Springer · DirectorSince 2023
-
Jeff Pavell · DirectorSince 2023
-
Robb Knie · Director · CEO and PresidentSince 2023
-
Wayne Linsley · DirectorSince 2023
Chief executives
Robb Knie
· CEO and President
Dates unknown
Director election results
Annual meeting of August 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.1%
-
91.8%
-
91.9%
-
91.9%
-
94.8%
Board connections
2 of this board's directors also sit on 2 other boards.
- via Jeff Pavell and Wayne Linsley
- via Wayne Linsley
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 28, 2025 | Robb Knie Director, Officer (CEO and President) | Shares withheld for tax | −310,744 | $1.21 | $376,000 |
| Aug 27, 2025 | Robb Knie Director, Officer (CEO and President) | Grant or award | +800,000 | — | — |
| Aug 16, 2024 | Robb Knie Director, Officer (CEO and President) | Open-market purchase | +25,000 | $0.67 | $16,750 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.